NIH Director Jay Bhattacharya Takes Temporary Helm at CDC

  Jay Bhattacharya, director of the National Institutes of Health, has been appointed acting director of the Centers for Disease Control and Prevention. He will continue to lead the NIH while temporarily overseeing CDC operations until Donald Trump selects a permanent director, a position that requires Senate confirmation. Bhattacharya replaces Jim O’Neill, who served as […]

Continue Reading

Rising Vaccine Exemptions Create Growing Health Risks in the U.S.

  The number of children in the United States skipping routine vaccinations is increasing, creating larger vulnerable populations and heightening the risk of outbreaks of preventable diseases such as measles, which is currently spreading at record levels in some regions. New research published in the medical journal JAMA indicates that exemptions from school-required vaccines have […]

Continue Reading

Food Preservatives Linked to Higher Cancer and Diabetes Risk

  Food preservatives are widely used to keep products fresh, prevent spoilage, and extend shelf life. However, new large-scale research from France suggests that frequent consumption of certain preservatives may be associated with a higher risk of developing cancer and type 2 diabetes, raising fresh concerns about the long-term health impact of heavily processed foods. […]

Continue Reading

Cholera Ravages Sudan Amid War and Collapse of Basic Services

Sudan is battling a severe health emergency as cholera continues to spread across the country, threatening millions of people. Since mid-2024, the disease has moved swiftly through cities, villages, and displacement settlements, driven by armed conflict, flooding, and the breakdown of essential services. In a nation already struggling to survive war, cholera has become another […]

Continue Reading

FDA Begins New Safety Review of RSV Antibody Treatments for Infants

  U.S. health regulators have launched a renewed safety examination of approved respiratory syncytial virus (RSV) preventive treatments for infants, according to sources familiar with the matter. Senior officials at pharmaceutical companies Merck, Sanofi, and AstraZeneca were informed last week that their RSV products would undergo additional scrutiny, despite already receiving regulatory approval. The therapies […]

Continue Reading